BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 14706487)

  • 21. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.
    Negrao BL; Bipath P; van der Westhuizen D; Viljoen M
    Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EEG Brain Wave Activity at Rest and during Evoked Attention in Children with Attention-Deficit/Hyperactivity Disorder and Effects of Methylphenidate.
    Thomas BL; Viljoen M
    Neuropsychobiology; 2016; 73(1):16-22. PubMed ID: 26812442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Event-Related Potentials Correlate with the Severity of Child and Adolescent Patients with Attention Deficit/Hyperactivity Disorder.
    Yamamuro K; Ota T; Iida J; Nakanishi Y; Suehiro Y; Matsuura H; Uratani M; Okazaki K; Kishimoto N; Tanaka S; Iwasaka H; Kishimoto T
    Neuropsychobiology; 2016; 73(3):131-8. PubMed ID: 27055108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
    Stein MA; Sarampote CS; Waldman ID; Robb AS; Conlon C; Pearl PL; Black DO; Seymour KE; Newcorn JH
    Pediatrics; 2003 Nov; 112(5):e404. PubMed ID: 14595084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
    Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J
    Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of methylphenidate on the ERP amplitude in youth with ADHD: A double-blind placebo-controlled cross-over EEG study.
    Rubinson M; Horowitz I; Naim-Feil J; Gothelf D; Levit-Binnun N; Moses E
    PLoS One; 2019; 14(5):e0217383. PubMed ID: 31150439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder.
    Reimherr FW; Williams ED; Strong RE; Mestas R; Soni P; Marchant BK
    J Clin Psychiatry; 2007 Jan; 68(1):93-101. PubMed ID: 17284136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive Testing to Identify Children With ADHD Who Do and Do Not Respond to Methylphenidate.
    Elliott GR; Blasey C; Rekshan W; Rush AJ; Palmer DM; Clarke S; Kohn M; Kaplan C; Gordon E
    J Atten Disord; 2017 Dec; 21(14):1151-1160. PubMed ID: 25122732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive performance and behavioral symptoms in patients with attention-deficit/hyperactivity disorder during twenty-four months of treatment with methylphenidate.
    Wang LJ; Chen CK; Huang YS
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):246-53. PubMed ID: 25574708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
    Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
    Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EEG correlates of methylphenidate response among children with ADHD: a preliminary report.
    Loo SK; Teale PD; Reite ML
    Biol Psychiatry; 1999 Jun; 45(12):1657-60. PubMed ID: 10376129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cognitive evoked potentials in the hyperactivity attention deficit disorder].
    Idiazábal Alecha M; Palencia Taboada AB; Sangorrín J; Espadaler-Gamissans JM
    Rev Neurol; 2002 Feb 16-28; 34(4):301-5. PubMed ID: 12022041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Event-related wave activity in the EEG provides new marker of ADHD.
    Alexander DM; Hermens DF; Keage HA; Clark CR; Williams LM; Kohn MR; Clarke SD; Lamb C; Gordon E
    Clin Neurophysiol; 2008 Jan; 119(1):163-79. PubMed ID: 18054279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment effect of methylphenidate on intrinsic functional brain network in medication-naïve ADHD children: A multivariate analysis.
    Yoo JH; Kim D; Choi J; Jeong B
    Brain Imaging Behav; 2018 Apr; 12(2):518-531. PubMed ID: 28417219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Attention-Deficit/Hyperactivity Disorder and Methylphenidate Treatment on the Adult Auditory Temporal Order Judgment Threshold.
    Fostick L
    J Speech Lang Hear Res; 2017 Jul; 60(7):2124-2128. PubMed ID: 28672285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder.
    Findling RL; Bukstein OG; Melmed RD; López FA; Sallee FR; Arnold LE; Pratt RD
    J Clin Psychiatry; 2008 Jan; 69(1):149-59. PubMed ID: 18312050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.
    Williams LM; Hermens DF; Palmer D; Kohn M; Clarke S; Keage H; Clark CR; Gordon E
    Biol Psychiatry; 2008 May; 63(10):917-26. PubMed ID: 18272140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Supervised off-label prescribing of methylphenidate in adult ADHD].
    Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
    Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence.
    Schubiner H; Saules KK; Arfken CL; Johanson CE; Schuster CR; Lockhart N; Edwards A; Donlin J; Pihlgren E
    Exp Clin Psychopharmacol; 2002 Aug; 10(3):286-94. PubMed ID: 12233989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.
    Salehi B; Imani R; Mohammadi MR; Fallah J; Mohammadi M; Ghanizadeh A; Tasviechi AA; Vossoughi A; Rezazadeh SA; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):76-80. PubMed ID: 19815048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.